February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Samer Al Hadidi: Oral Myeloma – Majestec-4/EMN30 presented at ASH24
Dec 11, 2024, 14:33

Samer Al Hadidi: Oral Myeloma – Majestec-4/EMN30 presented at ASH24

Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X:

ASH24 The American Society of Hematology (ASH)

Oral Myeloma: Majestec-4/EMN30

Schema:

Patients got 3-4 drugs with 1-2 transplants and needed to have at least partial response

Maintenance study:

Dosing intensity per 3 cohorts  Tec can be stopped after 1 year if in CR and at 2 years regardless, details.”

Samer Al Hadidi

More posts featuring Samer Al Hadidi.